We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MYSZ:NASDAQMy Size, Inc. Analysis

Data as of 2026-05-24 - not real-time

$0.49

Latest Price

8/10Risk

Risk Level: High

Executive Summary

My Size, Inc. is trading at $0.49, essentially hugging its recent support level of $0.48, while the 20‑day SMA (0.56) sits well below both the 50‑day (0.60) and 200‑day (0.89) averages, indicating a sustained downtrend. Technical momentum is weak – the RSI is near 28 (oversold), the MACD line remains bearish at –0.035, and the MACD histogram is negative, suggesting limited upside in the near term. Volatility is high at roughly 40% over the past 30 days and beta exceeds 1.1, amplifying price swings for a stock that already bears a massive 66% max drawdown. Fundamentally, the company posts negative operating and net margins, a sizable operating cash‑flow deficit, and a negative forward PE, yet valuation multiples are shallow (price‑to‑book 0.44, price‑to‑sales 0.23) compared with an industry PE average of nearly 40, hinting at a potential value floor. The balance sheet shows modest cash of $0.65 M against $1.28 M of debt, yielding a debt‑to‑equity of over 32%, which raises solvency concerns for a micro‑cap firm. The market sentiment is extreme greed (Fear‑Greed Index 91.6), but this appears disconnected from the underlying financial weakness. Upcoming exposure at the Market Movers Investor Summit could provide a short‑term catalyst, though the fundamental backdrop remains challenging.
Given the confluence of bearish technicals, high volatility, and weak earnings, the stock is best viewed as a speculative play with limited upside unless a material operational turnaround or strategic partnership materializes. Investors should weigh the low valuation against the deep cash‑flow deficits and liquidity constraints, recognizing that any upside is likely contingent on significant improvements in the AI‑driven fashion tech business model.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 3/10

Key Factors

  • Bearish technical indicators (RSI, MACD, SMA positioning)
  • Price near support with limited cushion
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential catalyst from investor summit presentation
  • Low valuation multiples relative to industry
  • Continued cash‑flow deficits and debt load

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Undervalued price‑to‑book and price‑to‑sales ratios
  • Need for a sustainable revenue growth model
  • High beta and volatility may deter risk‑averse investors

Key Metrics & Analysis

Financial Health

Revenue Growth61.90%
Profit Margin-60.99%
P/E Ratio-0.2
ROE-125.59%
ROA-43.09%
Debt/Equity32.35
P/B Ratio0.4
Op. Cash Flow$-5943000
Free Cash Flow$-3566500
Industry P/E39.5

Technical Analysis

TrendBearish
RSI27.9
Support$0.48
Resistance$0.67
MA 20$0.56
MA 50$0.60
MA 200$0.89
MACDBearish
VolumeStable
Fear & Greed Index91.61

Valuation

Target Price$3.00
Upside/Downside512.24%
GradeUndervalued
TypeValue

Risk Assessment

Beta1.15
Volatility39.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.